|
PCF11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.176000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.410600E-01 |
| Normal-vs-Stage2 |
6.778400E-01 |
| Normal-vs-Stage3 |
9.464400E-01 |
| Normal-vs-Stage4 |
5.857400E-01 |
| Stage1-vs-Stage2 |
8.287800E-01 |
| Stage1-vs-Stage3 |
4.476000E-01 |
| Stage1-vs-Stage4 |
1.758370E-01 |
| Stage2-vs-Stage3 |
7.543600E-01 |
| Stage2-vs-Stage4 |
4.285200E-01 |
| Stage3-vs-Stage4 |
5.890600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.863200E-01 |
| Normal-vs-AfricanAmerican |
5.525900E-02 |
| Normal-vs-Asian |
6.778100E-03 |
| Caucasian-vs-AfricanAmerican |
4.039900E-02 |
| Caucasian-vs-Asian |
5.998400E-02 |
| AfricanAmerican-vs-Asian |
2.903400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.150400E-01 |
| Normal-vs-Female |
8.157600E-03 |
| Male-vs-Female |
4.36369999999853E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.040800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.707200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.382400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.846600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.180600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.254400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.670800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.987610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.166400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.583800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.583780E-02 |
| Normal-vs-Grade 2 |
1.135350E-01 |
| Normal-vs-Grade 3 |
7.343200E-01 |
| Normal-vs-Grade 4 |
1.117960E-01 |
| Grade 1-vs-Grade 2 |
2.869900E-02 |
| Grade 1-vs-Grade 3 |
2.200400E-03 |
| Grade 1-vs-Grade 4 |
5.424700E-04 |
| Grade 2-vs-Grade 3 |
3.944000E-02 |
| Grade 2-vs-Grade 4 |
5.321900E-03 |
| Grade 3-vs-Grade 4 |
1.656430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.112300E-02 |
| Normal-vs-ccB subtype |
9.412300E-02 |
| ccA subtype-vs-ccB subtype |
4.06880000000109E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.631800E-01 |
| Normal-vs-N1 |
2.956200E-02 |
| N0-vs-N1 |
8.630400E-02 |
|
|
